Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CYAB vs TNMG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TNMG Wins Head-to-Head Institutional Verdict (3–0 across 6 Pillars · 7–1 Matrix Metrics)

TNMG Overall Winner 6-Pillar Tally: CYAB 0 – 3 TNMG (3 Tie) Matrix Metrics: CYAB 1 – 7 TNMG

As of Nov 20, 2026, TNL Mediagene (TNMG) is the stronger overall head-to-head candidate over CYAB (CYAB) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CYAB carries a Unified Composite Score of 48.4/100 (HOLD) at $0.06 (N/M Forward P/E, N/A operating margin), whereas TNMG carries 48.1/100 (HOLD) at $2.12 (N/M Forward P/E, -100.6% operating margin).

  • Technical & Structure Timing Caution: CYAB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2); meanwhile TNMG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 33.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CYAB vs TNMG
CYAB US Equity
CYAB
Institutional Equity
$0.06
-3.39% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.45β · 246% Vol
Unified Composite Score
48.4 / 100 HOLD
Tech 43.0 Fund 52.0 Flow 50.0 Mom 88.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -37.4%), weak momentum, RSI 32
RSI-14: 32.2 · SMA20: $0.10 · SMA50: $0.17
TNMG NASDAQ Head-to-Head Winner
TNL Mediagene Ordinary Shares
Services-Advertising
$2.12
-7.42% 1D
Market Cap $1.7M
TTM Revenue $50M
Forward P/E N/M
Beta / 30D Vol -0.58β · 135% Vol
Unified Composite Score
48.1 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 34
RSI-14: 33.6 · SMA20: $2.96 · SMA50: $3.42

6-Pillar Scorecard Institutional Category Breakdown (CYAB 0 – 3 TNMG)

Columns: Metric · CYAB · TNMG
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale TNMG
Revenue Growth (YoY) N/A +5.7%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $50M
Market Cap N/A $1.7M
3. Profitability & Quality TNMG
Gross Margin N/A 33.3%
Operating Margin N/A -100.6%
Net Profit Margin N/A -167.9%
Return on Equity (ROE) N/A -164.6%
4. Balance Sheet & Cash Flow TNMG
Cash Generation (TTM) N/A -$48M EBITDA
Cash Flow Margin N/A -96.6% EBITDA Mgn
Net Cash / Leverage N/A ROE $109.10 Book/Sh · -164.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Publishing Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CYAB (1) vs TNMG (7)
Institutional Metric CYAB TNMG Criterion Row Edge
Market Capitalization
Scale
N/A $1.7M Larger Scale TNMG
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +5.7% Higher Growth TNMG
Operating Margin (TTM)
Profitability
N/A -100.6% Higher Margin TNMG
Net Profit Margin
Profitability
N/A -167.9% Higher Margin TNMG
Return on Equity (ROE)
Capital Efficiency
N/A -164.6% Higher ROE TNMG
52-Week Range Position
Momentum
0% ($0–$6) 28% ($0–$7) Stronger Trend TNMG
Beta / 30D Volatility
Risk Regime
0.45β · 246% Vol -0.58β · 135% Vol Lower Realized Risk TNMG
Unified Institutional Score
Composite Signal
48.4 / 100 (HOLD) 48.1 / 100 (HOLD) Higher Composite CYAB
Trailing 12M Revenue (USD)
Operating Scale
N/A $50M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 33.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$48M EBITDA ($109.10 Book/Sh · -164.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TNMG +23.7 pp
CYAB: -56.18% · TNMG: -32.48%
3M Horizon TNMG +512.18 pp
CYAB: -79.25% · TNMG: +432.93%
6M Horizon TNMG +280.95 pp
CYAB: -89.06% · TNMG: +191.89%
1Y Horizon TNMG +112.89 pp
CYAB: -98.3% · TNMG: +14.59%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CYAB vs TNMG. Trailing 12-month operating profitability (CYAB N/A vs TNMG -100.6%) and valuation multiples (CYAB N/M vs TNMG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CYAB ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
TNMG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$50M
Gross Margin33.3%
Op. Margin-100.6%
ROE / Fwd P/E-164.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CYAB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CYAB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TNMG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TNMG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CYAB Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
TNMG Moat Profile Cyclical / Execution-Driven Positioning
Publishing Operator
Competes within the Publishing value chain with $1.7M market capitalization and -100.6% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CYAB vs TNMG Key Questions & Quantitative Answers

As of Nov 20, 2026, TNL Mediagene (TNMG) is the stronger overall head-to-head candidate over CYAB (CYAB) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CYAB carries a Unified Composite Score of 48.4/100 (HOLD) at $0.06 (N/M Forward P/E, N/A operating margin), whereas TNMG carries 48.1/100 (HOLD) at $2.12 (N/M Forward P/E, -100.6% operating margin). Technical & Structure Timing Caution: CYAB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.2); meanwhile TNMG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 33.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TNMG leads the Growth & Scale pillar: CYAB posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with TNMG at +5.7% YoY revenue growth and +0.0% YoY earnings growth on $50M TTM revenue (33.3% gross margin, -100.6% operating margin). On trailing 12-month operating scale, CYAB generates N/A in USD-normalized revenue versus $50M for TNMG. In operating R&D and SG&A reinvestment, CYAB deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TNMG.

CYAB and TNMG trade at balanced relative valuation multiples. CYAB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TNMG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-96.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CYAB (N/A ROE) versus TNMG (-164.6% ROE) capital efficiency.

In options market volatility and institutional positioning, CYAB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 246% Vol realized risk). By comparison, TNMG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.58β · 135% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.